Roberts, Deb · Patient related outcome measures · 2018 · DOI
Quick Summary
This study looked at how to measure quality of life in people with ME/CFS, since this condition affects many different aspects of daily living in complex ways. The researchers reviewed existing tools that ask patients about their wellbeing and found that current measures don't fully capture the unique experience of ME/CFS. They explored whether a standard quality-of-life questionnaire from the World Health Organization could work for ME/CFS patients and help doctors track how well treatments are working.
Why It Matters
Accurate measurement of quality of life is essential for understanding how ME/CFS affects patients' daily functioning and for evaluating whether treatments actually help. Without proper measurement tools, healthcare providers cannot fully understand patient experiences or track meaningful improvements, making this foundational work important for developing better patient-centered care and commissioning appropriate specialist services.
Observed Findings
No CFS/ME-specific quality-of-life patient-reported outcome measure was identified in the literature at the time of review.
Standard healthcare practice did not fully capture the complex, fluctuating symptom experience reported by ME/CFS patients.
The WHOQoL-Bref26 was available as an alternative measure but required evaluation for condition-specific relevance.
PROM tools can serve both clinical monitoring and therapeutic functions in specialist services.
Inferred Conclusions
Patient-reported outcome measures are necessary to understand the true impact of ME/CFS from the patient perspective.
Existing generic quality-of-life tools may not adequately assess the heterogeneous and fluctuating nature of ME/CFS symptoms.
Development or validation of a condition-specific QoL measure could improve clinical care and specialist service evaluation.
Regular interval measurement of quality of life could inform commissioning and delivery of NHS specialist ME/CFS services.
Remaining Questions
Has a validated, ME/CFS-specific quality-of-life measure been developed or validated since 2018?
How do patients' quality-of-life scores correlate with clinical markers or symptom severity in ME/CFS?
What This Study Does Not Prove
This review does not prove that any particular quality-of-life measure is definitively superior for ME/CFS, nor does it provide clinical trial data showing which interventions improve outcomes. It does not establish whether generic QoL tools are inadequate—only that a specific ME/CFS-validated measure had not yet been identified at the time of publication.